AOCIF:OTC-AutoCanada Inc (USD)

COMMON STOCK | Others | OTC

Last Closing Price

USD 11.96

Change

0.00 (0.00)%

Market Cap

USD 0.30B

Average Target Price

USD 13.25 (+10.79%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AutoCanada Inc., through its subsidiaries, operates franchised automobile dealerships in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, Nova Scotia, and New Brunswick, Canada; and Illinois, the United States. The company offers a range of automotive products and services, including new and used vehicles, vehicle leasing, vehicle parts, vehicle maintenance and collision repair services, extended service contracts, and vehicle protection and other after-market products. It also arranges financing and insurance for vehicle purchases by its customers through third-party finance and insurance sources. The company sells its vehicles under the Chrysler, Dodge, Jeep, Ram, FIAT, Alfa Romeo, Chevrolet, GMC, Buick, Cadillac, Ford, Infiniti, Nissan, Hyundai, Subaru, Audi, Volkswagen, Kia, Mazda, Mercedes-Benz, BMW, MINI, Volvo, Toyota, Lincoln, and Honda brands. As of April 20, 2020, it operated 63 franchised dealerships in Canada, as well as in Illinois. AutoCanada Inc. was incorporated in 2009 and is headquartered in Edmonton, Canada.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ABEC Analytica Bio-Energy Corp

N/A

USD790.71B 25.06 N/A
BTHI Big Time Holdings, Inc

N/A

USD151.65B N/A N/A
DFIFF Diamond Fields Resources Inc

-0.01 (-8.11%)

USD44.27B 39.43 N/A
HENOF Henkel AG & Co. KGaA

N/A

USD44.23B 11.51 N/A
SEMHF Siemens Healthineers AG

-0.44 (-0.99%)

USD43.39B 26.69 N/A
YACAF Yancoal Australia Ltd

N/A

USD41.57B 0.20 N/A
HDALF Haidilao International Holding..

N/A

USD38.90B 79.20 N/A
PETFF PTT Public Company Limited

N/A

USD34.53B 14.15 0.17
CSTNL iShares VII Public Limited Com..

-5.00 (-1.51%)

USD32.85B 19.50 N/A
WXIBF WuXi Biologics (Cayman) Inc

N/A

USD28.94B 259.38 N/A

ETFs Containing AOCIF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Others)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.56% 69% D+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.56% 69% D+ 70% C-
Trailing 12 Months  
Capital Gain 54.92% 79% C+ 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 54.92% 79% C+ 79% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.44% N/A N/A N/A N/A
Dividend Return 0.12% N/A N/A N/A N/A
Total Return 2.57% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.34% N/A N/A N/A N/A
Risk Adjusted Return 17.89% N/A N/A N/A N/A
Market Capitalization 0.30B 67% D+ 64% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Others)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 4.80 82% B- 82% B-
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 2.79 29% F 29% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -25.84% 29% F 27% F
Return on Invested Capital 12.36% 78% C+ 74% C
Return on Assets 1.90% 67% D+ 68% D+
Debt to Equity Ratio 62.07% 31% F 31% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 2.79 15% F 13% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector